Remarkably, of the validated genes only CDH5 was previously described in detail as showing LOH [11], which might be explained by the unbiased approach used to identify the breast cancer somatic mutome, or by the inexistence of LOH as a second-hit genetic mechanism common to this set of genes. The gene discussed is CDH5; the disease is breast cancer.